Teza Capital Management’s Celgene Corp CELG Stock Holding History

Teza Capital Management’s Portfolio CELG Stock Details CELG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q2	–	Sell	-11,366	Closed	-$1.01M	–	627
2018 Q1	$1.01M	Buy	11,366 +9,335	+460%	+$896K	0.24%	148
2017 Q4	$212K	Buy	+2,031	New	+$229K	0.13%	283
2017 Q1	–	Sell	-2,175	Closed	-$252K	–	644
2016 Q4	$252K	Buy	+2,175	New	+$242K	0.35%	124

Other funds holding CELG

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

HBK Investments Dallas, Texas $9.85B AUM 55.6% 1-Year Est. Return

Edgewood Management Greenwich, Connecticut $15.5B AUM 9.67% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return

OAG

Orbis Allan Gray Hamilton, Bermuda $23.7B AUM 65.43% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Teza Capital Management's CELG Position: Q2 2018 in Review

Teza Capital Management sold out of Celgene Corp (CELG) in Q2 2018, closing a stake of 11,366 shares — an estimated $1.01M sold.

Teza Capital Management first reported a position in CELG in Q4 2016 and held it in 3 quarters. The position peaked at $1.01M in Q1 2018. 1,360 funds tracked by Wall St. Rank hold CELG as of Q2 2018.

Teza Capital Management reported no remaining Celgene Corp position as of Q2 2018 after selling out during the quarter.
Teza Capital Management sold 11,366 Celgene Corp shares in Q2 2018, an estimated $1.01M.
Teza Capital Management first reported a position in Celgene Corp in Q4 2016 and held it in 3 quarters.
Teza Capital Management's Celgene Corp position peaked at $1.01M in Q1 2018.
1,360 funds tracked by Wall St. Rank held Celgene Corp as of Q2 2018.

Based on Teza Capital Management's 13F filing for Q2 2018, filed 14 Aug 2018.